Back to Agenda
Session 4 Track B: Global Promotional Review Process and Considerations
Session Chair(s)
Sue Duvall, MPA, RN
Head, North America Advertising and Promotion
Mylan, United States
There is an increasing need for consistency and alignment of marketing messages across regions as companies expand internationally and introduce their products into more markets. Global pharmaceutical companies are realizing the importance of establishing a clear and efficient process for the review of global messaging and draft materials by a multidisciplinary Global Promotional Review Committee prior to their distribution to local countries or Affiliates. The first part of this session will provide considerations and best practices for the global promotional review process. The second part will provide insights into how to navigate Canada’s drug advertising process.
Learning Objective : At the conclusion of this session, participants should be able to: - Describe various approaches to a global promotional review process
- Explain Canada’s drug advertising process and how it may impact a global promotion review process
- Identify best practices for the global promotional review process
Speaker(s)
Sue Duvall, MPA, RN
Sue Duvall, MPA, RN
Mylan, United States
Head, North America Advertising and Promotion
Speaker
John K. Wong, MPharm, RPh
ADWORX REG INC., Canada
Consultant
Speaker
Lisa Schatz, PharmD, MBA
Abbvie, United States
Director, International Regulatory Affairs Advertising and Promotion
Have an account?